Blog

Category

“Operation Warp Speed” Moves to Warp 2: AstraZeneca Begins Phase 3, Experts Skeptical as Trump Administration Prepares for November 1 Vaccine Delivery, and Speed-Up May Involve an EUA

Monday, AstraZeneca said it has begun Phase 3 trials of AZD1222, its COVID-19 vaccine candidate. This makes them the third firm to be in Phase 3 for the virus. As chronicled by CNN August 31 and updated September 1, the vaccine is developed with Oxford University and...

Zagazig University Randomized Controlled Ivermectin Study Results Confirms PI Hypothesis: Drug Effective Against COVID-19

A principal investor from Zagazig University, Dr. Waheed Shouman, recently completed a randomized, open label, interventional trial titled “Use of Ivermectin as Prophylactic Option in Asymptomatic Family Close Contact for Patient with COVID-19.” Targeting 340...

The AstraZeneca Phase 3 COVID-19 Vaccine Study: Unprecedented Compression of Timeline of Est. Start Date to Est. Primary Completion Date

Is President Trump preparing to fast track the AstraZeneca COVID-19 vaccine known as AZD1222? According to a report in the Financial Times, this is exactly what is being contemplated as the administration would “bypass normal regulatory standards to fast-track”...

TrialSite Inspection Readiness Service: Online Q&A

TrialSite proudly offers a compelling Site Inspection Readiness Service leveraging a team of clinical trials seasoned experts. Whether it’s monitoring, coordinator training, or site regulatory questions, the service’s goal is to offer compelling advisory services with...

OneOncology Expands to Southern California with the Los Angeles Cancer Network Joining the Platform for a Win-Win

OneOncology incorporated yet another community oncology provider, Los Angeles Cancer Network (LACN), into its growing network nationwide. This private equity-based group is developing an important model. OneOncology, on the one hand, seeks to embrace the realities of...

Pin It on Pinterest